The crowd were hungry for more, as reflected in the share price. Personally makes MSB a buy again for me, despite being a dreaded Cynutter too.
I am surprised the drop in price and availing myself of it. As investors we'd all be disappointed if they were not at one of these meetings, as a natural marketing of the potential to kol's (key opinion leaders) so they can begin to foster future take up for commercialisation pathways with the professionals that will. They are at presenting at both in tandem, all the better. This is all part and parcel of the softer side of the Ryconcil launch and it will not doubt be warmly embraced by the industry as the poster of child of stem cells with FDA allogeneic approval.
Perhaps some were expected fireworks. Perhaps many understandably want news on a big partnerships. Today perhaps a buy opportunity ahead of that likely eventuality, one day, IMO. I didn't think it would likely trade in the $2.70's again. Happy to be wrong and buy some more.
MSB Price at posting:
$2.79 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)